Clinical Trials
26 trialsTICE
Institut Claudius Regaud
CD30 CAR for CD30+ NSGCT
UNC Lineberger Comprehensive Cancer Center
Thalidomide Combined With Chemotherapy in the Treatment of Relapsed or Refractory Yolk Sac Tumor
Shandong First Medical University
Fluorescence Detection of Adult Primary Central Nervous System Tumors With Tozuleristide and the Canvas System
Cedars-Sinai Medical Center
Olaparib as Salvage Treatment for Cisplatin-resistant Germ Cell Tumor
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
GAMMA
Barts & The London NHS Trust
A Pilot RCT of the PRISM Intervention for AYAs With Cancer
Seattle Children's Hospital
GAMEC-II
Queen Mary University of London
AcSé
UNICANCER
DISGCT
National Cancer Institute, Slovakia
Memantine for Prevention of Cognitive Late Effects in Pediatric Patients Receiving Cranial Radiation Therapy for Localized Brain Tumors
St. Jude Children's Research Hospital
Pazotest-01
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
A Randomized, Blinded, Placebo-controlled, Phase II Trial of LEE011 in Patients With Relapsed, Refractory, Incurable Teratoma With Recent Progression
Novartis
TIP
National Cancer Institute, Slovakia
Stem Cell Transplant for High Risk Central Nervous System (CNS) Tumors
Ann & Robert H Lurie Children's Hospital of Chicago
Avelumab in Refractory Testicular Germ Cell Cancer.
National Cancer Institute, Slovakia
Brentuximab Vedotin (SGN-35) as Salvage Treatment for CD30-positive Germ Cell Tumors
Fondazione Michelangelo
Intra-arterial Y-90 TheraSpheres for Hepatic Metastases From Solid Tumors
Yale University
Study of Gemcitabine, Oxaliplatin, and Paclitaxel in Patients With Refractory Germ Cell Carcinoma
University of Southern California
Fosaprepitant + 5HT3 Receptor Antagonists + Dexamethasone in Germ Cell Tumors
Hoosier Cancer Research Network
Study of Oxaliplatin Plus Bevacizumab in Germ Cell Tumor Patients
Indiana University
Everolimus in Refractory Testicular Germ Cell Cancer
National Cancer Institute, Slovakia
RADIT
Hannover Medical School
Conventional Dose Versus High Dose Sequential Chemotherapy for Poor Prognosis Germ Cell Tumors
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase-II Study of SU011248 (Sunitinib)in Male Patients With Relapsed or Cisplatin-Refractory Germ Cell Cancer
British Columbia Cancer Agency
Phase II Study of Oxaliplatine-Paclitaxel in Patients With Metastatic Germ Cell Tumor Refractory to Cisplatin
Sanofi